PER 1.23% 8.0¢ percheron therapeutics limited

UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-10

  1. 1,516 Posts.
    lightbulb Created with Sketch. 1899
    Going back to the Pinto-Mariz paper, the authors found that the higher the relative number of CD49dhi T cells in the blood, the more rapid the disease progression. What is the corollary and what does this imply for early intervention @gbsm
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.